BOSTON and HYDERABAD, India, Oct. 10, 2024 /PRNewswire/ — Aryastha Life Sciences, a premier Contract Research, Development, and Manufacturing Organization is thrilled to announce the appointment of an elite team of senior executives to drive its Integrated Drug Discovery and Development and overall company scientific strategy. With a unique proposition, the team brings extensive experience, having filed 11 INDs, developed 6 clinical candidates, and worked on over 75 integrated drug discovery projects across various therapeutic indications. Co-founder and CEO Dr. Raghava Reddy Kethiri states, “There is no other company working with a biotech mindset and offering intellectual solutions to clients like Aryastha, especially in field of translational science. Our clients will benefit from the invaluable experience of our scientific/leadership team and cutting-edge technology platforms.”
